Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 1
2001 1
2003 2
2006 1
2011 1
2012 1
2013 1
2014 3
2015 2
2016 6
2017 3
2018 2
2019 3
2020 4
2021 3
2022 9
2023 6
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Healthcare-associated exposure to Borna disease virus 1 (BoDV-1).
Reinmiedl J, Schulz H, Ruf VC, Hernandez Petzsche MR, Rissland J, Tappe D. Reinmiedl J, et al. Among authors: rissland j. J Occup Med Toxicol. 2022 Jun 9;17(1):13. doi: 10.1186/s12995-022-00353-3. J Occup Med Toxicol. 2022. PMID: 35681207 Free PMC article. Review.
Long-term persistence of HCV resistance-associated substitutions after DAA treatment failure.
Dietz J, Müllhaupt B, Buggisch P, Graf C, Peiffer KH, Matschenz K, Schattenberg JM, Antoni C, Mauss S, Niederau C, Discher T, Trauth J, Dultz G, Schulze Zur Wiesch J, Piecha F, Klinker H, Müller T, Berg T, Neumann-Haefelin C, Berg CP, Zeuzem S, Sarrazin C; German HCV Resistance Study Group; University Hospitals; Academic Hospitals; Local study sites (private practices), Germany. Dietz J, et al. J Hepatol. 2023 Jan;78(1):57-66. doi: 10.1016/j.jhep.2022.08.016. Epub 2022 Aug 27. J Hepatol. 2023. PMID: 36031158
Human bornavirus research: Back on track!
Rubbenstroth D, Schlottau K, Schwemmle M, Rissland J, Beer M. Rubbenstroth D, et al. Among authors: rissland j. PLoS Pathog. 2019 Aug 1;15(8):e1007873. doi: 10.1371/journal.ppat.1007873. eCollection 2019 Aug. PLoS Pathog. 2019. PMID: 31369648 Free PMC article. No abstract available.
Time-dependent prediction of mortality and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation using machine learning.
Eisenberg L; XplOit consortium; Brossette C, Rauch J, Grandjean A, Ottinger H, Rissland J, Schwarz U, Graf N, Beelen DW, Kiefer S, Pfeifer N, Turki AT. Eisenberg L, et al. Among authors: rissland j. Am J Hematol. 2022 Oct;97(10):1309-1323. doi: 10.1002/ajh.26671. Epub 2022 Aug 15. Am J Hematol. 2022. PMID: 36071578 Free article.
Pooling of samples for testing for SARS-CoV-2 in asymptomatic people.
Lohse S, Pfuhl T, Berkó-Göttel B, Rissland J, Geißler T, Gärtner B, Becker SL, Schneitler S, Smola S. Lohse S, et al. Among authors: rissland j. Lancet Infect Dis. 2020 Nov;20(11):1231-1232. doi: 10.1016/S1473-3099(20)30362-5. Epub 2020 Apr 28. Lancet Infect Dis. 2020. PMID: 32530425 Free PMC article. No abstract available.
Efficacy of Retreatment After Failed Direct-acting Antiviral Therapy in Patients With HCV Genotype 1-3 Infections.
Dietz J, Spengler U, Müllhaupt B, Schulze Zur Wiesch J, Piecha F, Mauss S, Seegers B, Hinrichsen H, Antoni C, Wietzke-Braun P, Peiffer KH, Berger A, Matschenz K, Buggisch P, Backhus J, Zizer E, Boettler T, Neumann-Haefelin C, Semela D, Stauber R, Berg T, Berg C, Zeuzem S, Vermehren J, Sarrazin C; European HCV Resistance Study Group. Dietz J, et al. Clin Gastroenterol Hepatol. 2021 Jan;19(1):195-198.e2. doi: 10.1016/j.cgh.2019.10.051. Epub 2019 Nov 6. Clin Gastroenterol Hepatol. 2021. PMID: 31706062 Free article.
Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients.
Dietz J, Graf C, Berg CP, Port K, Deterding K, Buggisch P, Peiffer KH, Vermehren J, Dultz G, Geier A, Reiter FP, Bruns T, Schattenberg JM, Durmashkina E, Gustot T, Moreno C, Trauth J, Discher T, Fischer J, Berg T, Kremer AE, Müllhaupt B, Zeuzem S, Sarrazin C; European HCV Resistance Study Group. Dietz J, et al. JHEP Rep. 2024 Mar 25;6(7):101072. doi: 10.1016/j.jhepr.2024.101072. eCollection 2024 Jul. JHEP Rep. 2024. PMID: 39006503 Free PMC article.
46 results